> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Debarment Ordered in Unapproved Drugs Case
- URL: https://www.fdaweb.com/debarment-ordered-in-unapproved-drugs-case/
- Published: 2018-01-18T12:00:00.000Z
- Updated: 2026-09-14T23:15:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140529

*Federal Register* notice: FDA has permanently debarred **William Ralph Kincaid** from providing services in any capacity to a person that has an approved or pending drug product application. The debarment is based on Kincaid’s felony conviction in 2013 after pleading guilty to receiving in interstate commerce a misbranded drug with intent to defraud or mislead. He admitted that he obtained over $2 million in unapproved drugs from Quality Specialty Products (QSP), a foreign company, for use at East Tennessee Hematology-Oncology Associates. Additionally, Kincaid and McLeod Cancer billed Medicare, TennCare, and other government health benefit programs approximately $2.5 million for these unapproved drugs. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-01-18/pdf/2018-00719.pdf?ref=fdaweb.com).